This week, we will discuss the use of renal autologous cell therapy (REACT) in diabetic kidney disease.
This week, we will discuss 2026 KDIGO anemia management in patients with kidney disease
This week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant.
This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.
What the hell is CHIP and why do I need to know about it?
Check out this rapid summary by the talented and creative Tiffany Caza!
Did you miss the last #NephJC? Check out this #TenTweetNephJC to catch up! pic.twitter.com/7oT34h2vzx
— Nephrology Jrnl Club (@NephJC) May 24, 2022
NSMC intern Mohamed Ibrahim created a beautiful visual abstract which simplifies the findings of CHIP study.
